Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum 14-3-3η is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritis.
Maksymowych WP, Naides SJ, Bykerk V, Siminovitch KA, van Schaardenburg D, Boers M, Landewé R, van der Heijde D, Tak PP, Genovese MC, Weinblatt ME, Keystone EC, Zhukov OS, Abolhosn RW, Popov JM, Britsemmer K, van Kuijk AW, Marotta A. Maksymowych WP, et al. Among authors: marotta a. J Rheumatol. 2014 Nov;41(11):2104-13. doi: 10.3899/jrheum.131446. Epub 2014 Aug 15. J Rheumatol. 2014. PMID: 25128504 Free article.
14-3-3η Autoantibodies: Diagnostic Use in Early Rheumatoid Arthritis.
Maksymowych WP, Boire G, van Schaardenburg D, Wichuk S, Turk S, Boers M, Siminovitch KA, Bykerk V, Keystone E, Tak PP, van Kuijk AW, Landewé R, van der Heijde D, Murphy M, Marotta A. Maksymowych WP, et al. Among authors: marotta a. J Rheumatol. 2015 Sep;42(9):1587-94. doi: 10.3899/jrheum.141385. Epub 2015 Jul 15. J Rheumatol. 2015. PMID: 26178283
14-3-3η in "Seronegative" Rheumatoid Arthritis.
Naides SJ, Marotta A. Naides SJ, et al. Among authors: marotta a. J Rheumatol. 2015 Oct;42(10):1995. doi: 10.3899/jrheum.150330. J Rheumatol. 2015. PMID: 26429210 No abstract available.
Serum levels of 14-3-3η protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis.
Carrier N, Marotta A, de Brum-Fernandes AJ, Liang P, Masetto A, Ménard HA, Maksymowych WP, Boire G. Carrier N, et al. Among authors: marotta a. Arthritis Res Ther. 2016 Feb 1;18:37. doi: 10.1186/s13075-016-0935-z. Arthritis Res Ther. 2016. PMID: 26832367 Free PMC article. Clinical Trial.
The diagnostic value of 14-3-3η protein levels in patients with rheumatoid arthritis.
Shovman O, Gilburd B, Watad A, Amital H, Langevitz P, Bragazzi NL, Adawi M, Perez D, Bornstein G, Grossman C, Lidar M, Blank M, Azuri J, Biln NK, Marotta A, Shoenfeld Y. Shovman O, et al. Among authors: marotta a. Best Pract Res Clin Rheumatol. 2018 Aug;32(4):610-617. doi: 10.1016/j.berh.2019.01.010. Epub 2019 Feb 21. Best Pract Res Clin Rheumatol. 2018. PMID: 31174829
Decrease in 14-3-3η protein levels is correlated with improvement in disease activity in patients with rheumatoid arthritis treated with Tofacitinib.
Shovman O, Gilburd B, Watad A, Amital H, Langevitz P, Bragazzi NL, Adawi M, Perez D, Lidar M, Katz I, Blank M, Biln NK, Marotta A, Shoenfeld Y. Shovman O, et al. Among authors: marotta a. Pharmacol Res. 2019 Mar;141:623-626. doi: 10.1016/j.phrs.2018.11.009. Epub 2018 Nov 8. Pharmacol Res. 2019. PMID: 30414892
184 results